Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01653054 · ClinicalTrials.gov registry record · NA
Anal Dysplasia in Patients With Inflammatory Bowel Disease
A NA study, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT01653054 is a NA study that has completed, run by Montefiore Medical Center. The registered enrollment target is 40 participants.
The verdict
NCT01653054, a NA study, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The rationale for this study is that the risk of anal dysplasia in patients with inflammatory bowel disease (IBD) as compared to the general population has yet to be investigated prospectively. There have only been a few articles examining this relationship - preliminary results have suggested that patients with IBD are at increased risk for abnormal anal pap smears. As high grade anal dysplasia is strongly associated with an increased risk of anal carcinoma, it is important to identify all high risk groups that might benefit from routine screening. This pilot study aims to determine whether patients with IBD in our Bronx population have an increased risk of abnormal anal Pap smears. We hypothesize that there will be an increased incidence of abnormal anal pap smears in patients with IBD who have been treated with immunosuppressants, given that chronic immunosuppression is related to increased HPV infection.
Interventions
- PROCEDURE Anal Pap Smear, HPV DNA Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2011-10 |
| Est. Completion | 2015-09-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01653054
The ClinicalTrials.gov registry entry for NCT01653054 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Anal Pap Smear, HPV DNA Testing is the first listed.
NCT01653054 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01653054 about?
NCT01653054 is a clinical study titled "Anal Dysplasia in Patients With Inflammatory Bowel Disease". The rationale for this study is that the risk of anal dysplasia in patients with inflammatory bowel disease (IBD) as compared to the general population has yet to be investigated prospectively. There have only been a few articles examining this relationship - preliminary results have suggested that ...
What is the current status of trial NCT01653054?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2011-10. Estimated completion is 2015-09-29.
What interventions are being tested in trial NCT01653054?
The interventions under investigation include: Anal Pap Smear, HPV DNA Testing (PROCEDURE).
Who is sponsoring clinical trial NCT01653054?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.